表紙
市場調查報告書

疫苗的中國市場·給藥數量的預測

China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type, Products, Company

出版商 Renub Research 商品編碼 918648
出版日期 內容資訊 英文 289 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
疫苗的中國市場·給藥數量的預測 China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type, Products, Company
出版日期: 2019年12月01日內容資訊: 英文 289 Pages
簡介

本報告提供中國的疫苗市場相關調查分析,提供市場動態,市場概要,市場佔有率,法規形勢,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長促進因素
  • 課題
  • 機會

第5章 中國的疫苗市場

  • 公共
  • 民間

第6章 中國的疫苗給藥數量

  • 公共
  • 民間

第7章 市場佔有率 - 中國的疫苗分析

  • 各部門
  • 疫苗給藥數量佔有率
  • 各產品類型
  • 各疾病類型

第8章 腦膜炎性腦膜炎疫苗

  • 市場
  • 疫苗給藥數量
  • 疫苗開發平台

第9章 肺炎球菌疫苗

  • 市場
  • 疫苗給藥數量
  • 疫苗開發平台

第10章 DTP疫苗

  • 市場
  • 疫苗給藥數量
  • 疫苗開發平台

第11章 狂犬病(恐水症)疫苗市場

第12章 伊波拉疫苗市場

  • 市場
  • 疫苗開發平台

第13章 各產品類型 - 中國的疫苗市場

  • MCV4
  • MPSV4
  • MCV2-Hib
  • MCV2
  • MPSV2,Men A
  • PCV13
  • PPV23

第14章 中國的疫苗法規當局

第15章 前往中國必要和建議施打的疫苗

第16章 M&A

第17章 企業分析

  • Sinopharm Group (China National Biotec Group Company Limited)
  • Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
  • Chongqing Zhifei Biological Products Co Ltd
  • Hualan Biological Engineering Inc.
  • Liaoning Chengda Co. Ltd.
  • Walvax Biotechnology Co. Ltd.
目錄

Vaccines are developed to address the public health needs. In China, vaccines are available through the government programmed called "Expanded Program on Immunization" at free for all children up to 14 years of age. However private sector vaccines such as Rabies Vaccine, Influenza Vaccine and Haemophilus Influenza Type B vaccine are also available in China but are usually paid for out-of-pocket as these are neither include in government EPI program nor government health insurance schemes. China Vaccine Market has great potential due to its vast population; so, its market size is projected to cross over US$ 9 Billion by 2025.

China vaccine market is divided into public and private vaccine market. Public market is classified by Category 1 whereas and Private vaccines included in Category 2. Vaccines in the public market are regulated by PRC government and generally given free of cost by provincial CDC whereas private vaccine market is dominating by private vaccine companies. As a result, private vaccines prices are higher. China vaccine market has faced several scandals in past couple of years which certainly hinder the vaccine market growth.

Renub Research report titled "China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type (Meningococcal Meningitis, Pneumococcal, DTP, Ebola, Rabies, Others), Products (MCV4, MPSV4, MCV2-Hib, MCV2, MPSV2 and Men A, PCV13, PPV23, Others), Company (Sinopharm Group, Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd, Chongqing Zhifei Biological Products Co Ltd, Hualan Biological Engineering Inc, Liaoning Chengda Co Ltd, Walvax Biotechnology Co Ltd)" provides a complete analysis of China Vaccine Market.

Sectors - Vaccine Market & Doses in China

  • Public
  • Private

Disease Type Market - Meningococcal Meningitis, Pneumococcal and DTP Vaccine Market has significant Market Share in China Vaccine Market

On the basis of disease type, Meningococcal meningitis, Pneumococcal and DTP Vaccine market is expected to control major portion of China vaccine market. Vaccine market in China is segmented into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others.

Products - PCV13 Drives Vaccine Market in China

In terms of products, PCV13 hold the maximum share of the China vaccine market. It is predicted that PCV13 will maintain their leading place during the forecasting period as well. Products included in this report are as follows:

  • MCV4
  • MPSV4
  • MCV2-Hib
  • MCV2
  • MPSV2 and Men A
  • PCV13
  • PPV23

Public and Private Vaccine Market & Doses

This report provides the detailed analysis of public and private vaccine market in China. Report also provides private and public vaccine doses in China.

Company Analysis:

All the companies covered in the report has been covered from the following points

  • Overview
  • Recent Development
  • Vaccine Pipeline
  • Revenue Analysis

Key Company Covered - China Vaccine Market

  • Sinopharm Group (China National Biotec Group Company Limited)
  • Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
  • Chongqing Zhifei Biological Products Co Ltd
  • Hualan Biological Engineering Inc
  • Liaoning Chengda Co Ltd
  • Walvax Biotechnology Co Ltd

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1. Growth Drivers
    • 4.1.1. High Quality Vaccines
    • 4.1.2. Growing Number of Aging Population
    • 4.1.3. Increasing Awareness
    • 4.1.4. Increasing Government Expenditure
    • 4.1.5. Affordability of Vaccines
  • 4.2. Challenges
    • 4.2.1. Research and Development Capabilities
    • 4.2.2. Stringent Quality Management System
    • 4.2.3. Long Development Time Frame
    • 4.2.4. Intensive Capital Requirement
  • 4.3. Opportunities
    • 4.3.1. Implementation of Two Child Policy
    • 4.3.2. Improving Vaccine Provision and Access

5. China Vaccine Market

  • 5.1. Public
  • 5.2. Private

6. China Vaccine Doses

  • 6.1. Public
  • 6.2. Private

7. Market Share - China Vaccine Analysis

  • 7.1. By Sectors
  • 7.2. By Vaccine Doses Share
  • 7.3. By Products Type
  • 7.4. By Disease Type

8. Meningococcal Meningitis Vaccine

  • 8.1. Market
    • 8.1.1. Total China
    • 8.1.2. Public
    • 8.1.3. Private
  • 8.2. Vaccine Doses
    • 8.2.1. Total China
    • 8.2.2. Public
    • 8.2.3. Private
  • 8.3. Vaccine Pipeline

9. Pneumococcal Vaccines

  • 9.1. Market
  • 9.2. Doses
  • 9.3. Vaccine Pipeline

10. DTP Vaccine

  • 10.1. Market - DTP Vaccine
    • 10.1.1. DTaP Vaccine
    • 10.1.2. DTcP and Combination Vaccine
  • 10.2. Doses - DTP Vaccine
    • 10.2.1. Public
    • 10.2.2. Private
  • 10.3. Vaccine Pipeline

11. Rabies Vaccine Market

12. Ebola Vaccine

  • 12.1. Market
  • 12.2. Vaccine Pipeline

13. Products Type - China Vaccine Market

  • 13.1. MCV4
  • 13.2. MPSV4
  • 13.3. MCV2-Hib
  • 13.4. MCV2
  • 13.5. MPSV2 and Men A
  • 13.6. PCV13
  • 13.7. PPV23

14. Vaccine Regulatory Authority of China

15. Required and Recommended Vaccinations for China Travel

16. Mergers and Acquisitions

17. Company Analysis

  • 17.1. Sinopharm Group (China National Biotec Group Company Limited)
    • 17.1.1. Overview
    • 17.1.2. Recent Development
    • 17.1.3. Vaccine Pipeline
    • 17.1.4. Revenue Analysis
  • 17.2. Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
    • 17.2.1. Overview
    • 17.2.2. Recent Development
    • 17.2.3. Vaccine Pipeline
    • 17.2.4. Revenue Analysis
  • 17.3. Chongqing Zhifei Biological Products Co Ltd
    • 17.3.1. Overview
    • 17.3.2. Recent Development
    • 17.3.3. Vaccine Pipeline
    • 17.3.4. Revenue Analysis
  • 17.4. Hualan Biological Engineering Inc.
    • 17.4.1. Overview
    • 17.4.2. Recent Development
    • 17.4.3. Revenue Analysis
  • 17.5. Liaoning Chengda Co. Ltd.
    • 17.5.1. Overview
    • 17.5.2. Recent Development
    • 17.5.3. Revenue Analysis
  • 17.6. Walvax Biotechnology Co. Ltd.
    • 17.6.1. Overview
    • 17.6.2. Recent Development
    • 17.6.3. Vaccine Pipeline
    • 17.6.4. Revenue Analysis

List of Figures:

  • Figure-01: China Vaccine Market in (Million US$), 2018 & 2025
  • Figure-02: China - Private Vaccine Market Growing Segment in (Million US$), 2018 - 2025
  • Figure-03: China - Vaccine Market in (Million US$) 2014 - 2018
  • Figure-04: China - Forecast for Vaccine Market in (Million US$) 2019 - 2025
  • Figure-05: China - Public Vaccine Market (Million US$) 2014 - 2018
  • Figure-06: China - Forecast for Public Vaccine Market in (Million US$) 2019 - 2025.
  • Figure-07: China - Private Vaccine Market in (Million US$) 2014 - 2018
  • Figure-08: China - Forecast for Private Vaccine Market in (Million US$) 2019 - 2025
  • Figure-09: China Vaccine Doses in (Million), 2014 - 2018
  • Figure-10: China - Forecast for Vaccine Doses in (Million), 2019 - 2025
  • Figure-11: China Public Vaccine Doses in (Million ), 2014 - 2018
  • Figure-12: China - Forecast for Public Vaccine Doses in (Million), 2019 - 2025
  • Figure-13: China Private Vaccine Doses in (Million ), 2014 - 2018
  • Figure-14: China - Forecast for Private Vaccine Doses in (Million), 2019 - 2025
  • Figure-15: China - Vaccine Market Share by Sectors in (Percent), 2014 - 2018
  • Figure-16: China - Forecast Vaccine Market Share by Sectors in (Percent), 2019 - 2025
  • Figure-17: China - Vaccine Market Share by Doses in (Percent), 2014 - 2018,
  • Figure-18: China - Forecast for Vaccine Market Share by Doses in (Percent), 2019 - 2025
  • Figure-19: China - Meningococcal Meningitis Vaccine Market (Million US$), 2014 - 2018
  • Figure-20: China - Forecast For Meningococcal Meningitis Vaccine Market (Million US$), 2019- 2025
  • Figure-21: Public - Meningococcal Meningitis Vaccine Market (Million US$), 2014 - 2018
  • Figure-22: Public - Forecast for Meningococcal Meningitis Vaccine Market (Million US$), 2019 - 2025
  • Figure-23: Private - Meningococcal Meningitis Vaccine Market (Million US$), 2014 - 2018
  • Figure-24: Private - Forecast for Meningococcal Meningitis Vaccine Market (Million US$), 2019 - 2025
  • Figure-25: China - Meningococcal Meningitis Doses (Million), 2014 - 2018
  • Figure-26: China - Forecast for Meningococcal Meningitis Doses (Million), 2019 - 2025
  • Figure-27: Public - Meningococcal Meningitis Doses (Million), 2014 - 2018
  • Figure-28: Public - Forecast for Meningococcal Meningitis Doses (Millions), 2019 - 2025
  • Figure-29: Private - Meningococcal Meningitis Doses (Million), 2014 - 2018
  • Figure-30: Private - Forecast for Meningococcal Meningitis Doses (Millions), 2019 - 2025
  • Figure-31: China - Pneumococcal Vaccines Market (Million US$), 2014 - 2018
  • Figure-32: China - Forecast For Pneumococcal Vaccines Market (Million US$), 2019 - 2025
  • Figure-33: China - Pneumococcal Vaccines Doses (Million), 2014 - 2018
  • Figure-34: China - Forecast For Pneumococcal Vaccines Doses in Million, 2019 - 2025
  • Figure-35: China - DTP Vaccine Market (US$ Million), 2014 - 2018
  • Figure-36: China - Forecast For DTP Vaccine Market in (US$ Million), 2019 - 2025
  • Figure-37: China - DTaP Vaccines Market in (US$ Million), 2014 - 2018
  • Figure-38: China - Forecast For DTaP Vaccines in (Million US$) ,2019 - 2025
  • Figure-39: China - DTcP Vaccine Market in (US$ Million), 2014 - 2018
  • Figure-40: China - Forecast for DTcP Vaccine Market in (Million US$), 2019 - 2025
  • Figure-41: China - DTP Vaccine Doses in (Million), 2014 - 2018
  • Figure-42: China - Forecast For DTP Vaccine Doses in (Million), 2019 - 2025
  • Figure-43: China - DTP Public Vaccine Doses (in Million), 2014 - 2018
  • Figure-44: China - Forecast for DTP Public Vaccine Doses (in Million), 2019 - 2025
  • Figure-45: China - DTP Private Vaccine Doses in (Million), 2014 - 2018
  • Figure-46: China - Forecast for DTP Private Vaccine Doses in (Million), 2019 - 2025
  • Figure-47: China - Rabies Vaccine Market in (Million US$), 2014 - 2018
  • Figure-48: China - Forecast For Rabies Vaccine Market in (Million US$) , 2019 - 2025
  • Figure-49: China - Ebola Vaccine Market in (Million US$), 2018 - 2025
  • Figure-50: China - Forecast for MCV4 Vaccine Market in (Million US$), 2020 - 2025
  • Figure-51: China - MPSV4 Vaccine Market in (Million US$), 2017 - 2018
  • Figure-52: China - Forecast For MPSV4 Vaccine Market in (Million US$), 2019 - 2025
  • Figure-53: China - MCV2-Hib Vaccine Market in (Million US$), 2017 - 2018
  • Figure-54: China - Forecast For MCV2-Hib Vaccine Market in (Million US$), 2019 - 2025
  • Figure-55: China - MCV2 Vaccine Market in (Million US$), 2017 - 2018
  • Figure-56: China - Forecast For MCV2 Vaccine Market in (Million US$), 2019 - 2025
  • Figure-58: China - MPSV2 and Men A Vaccine Market in (Million US$), 2017 - 2018
  • Figure-59: China - Forecast For MPSV2 and Men A Vaccine Market in (Million US$), 2019 - 2025
  • Figure-60: China - PCV13 Vaccine Market in (Million US$), 2017 - 2018
  • Figure-61: China - Forecast for PCV13 Vaccine Market in (Million US$), 2019 - 2025
  • Figure-62: China - PPV23 Vaccine Market in (Million US$), 2017 - 2018
  • Figure-63: China - Forecast For PPV23 Vaccine Market in (Million US$), 2019 - 2025
  • Figure-64: Global - Sinopharm Group Revenue in (Million US$) , 2014 - 2018
  • Figure-65: Global - Forecast For Sinopharm Group Revenue (Million US$), 2019 - 2025
  • Figure-66: Global -Sinovac Biotech Revenue in (Million US$) 2014 - 2018
  • Figure-67: Global - Forecast For Sinovac Biotech Revenue in (Million US$), 2019 - 2025
  • Figure-68: Global -Chongqing Zhifei Revenue in (US$ Million), 2014 - 2018
  • Figure-69: Global - Forecast For Chongqing Zhifei Revenue in (Million US$), 2019 - 2025
  • Figure-70: Global - Hualan Biological in Revenue (Million US$), 2014 - 2018
  • Figure-71: Global - Forecast For Hualan Biological Revenue in (Million US$), 2019 - 2025
  • Figure-72: Global - Liaoning Chengda Revenue in (Million US$), 2014 - 2018
  • Figure-73: Global- Forecast For Liaoning Chengda Revenue in (Million US$), 2019 - 2025
  • Figure-74: Global - Walvax Biotechnology Revenue (Million US$), 2014 - 2018
  • Figure-75: Global - Forecast For Walvax Biotechnology Revenue in (Million US$), 2019 - 2025

List of Tables:

  • Table-01: China - Vaccine Market Share by Products in (Percent), 2017 - 2018
  • Table-02: China - Forecast for Vaccine Market Share by Products in (Percent), 2019 - 2025
  • Table-03: China - Vaccine Market Share by Diseases in (Percent), 2014 - 2018
  • Table-04: China - Forecast for Vaccine Market Share by Diseases in (Percent), 2019 - 2025
Back to Top